Skip to content
PICO Portalanswers from OpenAlex

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response

PaperCitations, authors & open-access status

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response is a paper indexed in PICO Portal from OpenAlex.

How many citations does Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response have?

PICO Portalcitation count

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response has 414 citations in the OpenAlex counts PICO Portal stores.

When was Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response published?

PICO Portalyear

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response has 2012 year in the PICO Portal index.

What is the open-access status of Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response?

PICO Portaloa status

Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response has bronze oa status in the PICO Portal index.

What is the DOI of Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response?

PICO Portaldoi

The DOI for Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response is on the source record.

What is the PMID of Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response?

PICO Portalpmid

The PMID for Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response is on the source record.

What is the OpenAlex record for Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response?

PICO Portalopenalex

The OpenAlex for Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial